Cargando…

The O'Leary‐Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP‐116D, 50% dimethyl sulfoxide solution

OBJECTIVES: To evaluate the efficacy of intravesical KRP‐116D, 50% dimethyl sulfoxide solution, in interstitial cystitis/bladder pain syndrome patients with Hunner lesions (Hunner‐type interstitial cystitis), and to evaluate the correlations between efficacy variables and global response assessment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Naoki, Uno, Takashi, Sasaki, Mitsuru, Ohinata, Akira, Nawata, Shigeki, Ueda, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles: Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300131/ https://www.ncbi.nlm.nih.gov/pubmed/34929761 http://dx.doi.org/10.1111/iju.14765

Ejemplares similares

Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary–Sant symptom index
por: Pires, Maria Verônica, et al.
Publicado: (2022)

O’Leary-Sant Symptom Index Predicts the Treatment Outcome for Onabotulinumtoxin A Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome
por: Kuo, Yuh-Chen, et al.
Publicado: (2015)

Non-Hunner's Interstitial Cystitis Is Different from Hunner's Interstitial Cystitis and May Be Curable by Uterosacral Ligament Repair
por: Goeschen, Klaus, et al.
Publicado: (2022)

Dr. O'Leary, on Yellow Fever
por: O'Leary, Edmond
Publicado: (1806)

Deep Learning Models for Cystoscopic Recognition of Hunner Lesion in Interstitial Cystitis
por: Iwaki, Takuya, et al.
Publicado: (2023)

Efficacy and safety of intravesical instillation of KRP‐116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double‐blind, placebo‐controlled, clinical study
por: Yoshimura, Naoki, et al.
Publicado: (2021)

Relationship between the frequency of electrocautery of Hunner lesions and changes in bladder capacity in patients with Hunner type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2021)

Elimination of Hunner's Ulcers by Fulguration in Patients With Interstitial Cystitis: Is It Effective and Long Lasting?
por: Ryu, Jeman, et al.
Publicado: (2013)

Recurrence after postoperative intravesical instillation therapy in Hunner type interstitial cystitis
por: Ko, Kwang Jin, et al.
Publicado: (2023)

Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2016)

Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner’s lesion cause bladder contraction?
por: Tomoe, Hikaru, et al.
Publicado: (2019)

Identification of novel biomarkers in Hunner’s interstitial cystitis using the CIBERSORT, an algorithm based on machine learning
por: Lu, Kaining, et al.
Publicado: (2021)

Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial Cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023)

Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives
por: Akiyama, Yoshiyuki
Publicado: (2021)

Therapeutic Endoscopic Treatment Plus Maintenance Dimethyl Sulfoxide Therapy Prolongs Recurrence-Free Time in Patients With Hunner Type Interstitial Cystitis: A Pilot Study
por: Otsuka, Atsushi, et al.
Publicado: (2019)

Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women With Interstitial Cystitis/Bladder Pain Syndrome
por: Ahn, Sun Tae, et al.
Publicado: (2018)

Neuroinflammatory gene expression analysis reveals potential novel mediators and treatment targets in interstitial cystitis with Hunner lesions
por: Werneburg, Glenn T., et al.
Publicado: (2021)

Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion
por: Saha, Subbroto Kumar, et al.
Publicado: (2020)

Reduction of Bladder Capacity Under Anesthesia Following Multiple Recurrences and Repeated Surgeries of Hunner Lesions in Patients With Interstitial Cystitis
por: Furuta, Akira, et al.
Publicado: (2022)

Integrated Analysis of Microarray Studies to Identify Novel Diagnostic Markers in Bladder Pain Syndrome/Interstitial Cystitis with Hunner Lesion
por: Cheng, Xiao-Feng, et al.
Publicado: (2022)

Pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis with Hunner’s lesions or glomerulations: systematic review and meta-analysis
por: Grigoryan, Bagrat, et al.
Publicado: (2022)

The Japanese Herbal Medicine Yokukansan Exerted Antioxidant and Analgesic Effects in an Experimental Rat Model of Hunner-Type Interstitial Cystitis
por: Inoue, Tatsuki, et al.
Publicado: (2022)

Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023)

Co-Morbidities of Interstitial Cystitis
por: Chelimsky, Gisela, et al.
Publicado: (2012)

Interstitial cystitis intravesical therapy
por: Ha, Tanya, et al.
Publicado: (2017)

Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion
por: Choi, Daeheon, et al.
Publicado: (2018)

Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023)

Development of the Interstitial Cystitis Self-Help and Medical Resources Scale (ICSR) for Women with Interstitial Cystitis
por: Chen, Hui-Chun, et al.
Publicado: (2022)

Current guidelines in the management of interstitial cystitis
por: Colaco, Marc, et al.
Publicado: (2015)

How does interstitial cystitis begin?
por: Parsons, C. Lowell
Publicado: (2015)

An update on treatment options for interstitial cystitis
por: Garzon, Simone, et al.
Publicado: (2020)

Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation
por: Maeda, Daichi, et al.
Publicado: (2015)

A Prospective Observational Study of the Recurrence Characteristics of Hunner Lesion After Repeated Transurethral Ablation in Patients With Interstitial Cystitis/Bladder Pain Syndrome
por: Ko, Kwang Jin, et al.
Publicado: (2022)

The Use of Urine Proteomic and Metabonomic Patterns for the Diagnosis of Interstitial Cystitis and Bacterial Cystitis
por: Van, Que N., et al.
Publicado: (2004)

Accelerating the research‐to‐practice translation of eating disorder apps and other digital interventions: Commentary on O'Leary and Torous (2022)
por: Graham, Andrea K., et al.
Publicado: (2022)

From interstitial cystitis to chronic pelvic pain
por: Persu, C, et al.
Publicado: (2010)

Metabolomics Insights Into Pathophysiological Mechanisms of Interstitial Cystitis
por: Fiehn, Oliver, et al.
Publicado: (2014)

Recent advances in imaging and understanding interstitial cystitis
por: Tyagi, Pradeep, et al.
Publicado: (2018)

Interstitial cystitis: an enigmatic disorder of unclear aetiology
por: Moutzouris, Dimitrios-Anestis, et al.
Publicado: (2008)

Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
por: Mykoniatis, Ioannis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eelbe28vtu8uhggh7b8ip29l8h